Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;21 Suppl 2:208-315.
doi: 10.1111/ajt.16494.

OPTN/SRTR 2019 Annual Data Report: Liver

Affiliations
Free article

OPTN/SRTR 2019 Annual Data Report: Liver

A J Kwong et al. Am J Transplant. 2021 Feb.
Free article

Abstract

This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acuity circle liver distribution policy was also implemented but reverted to donor service area- and region-based boundaries after 1 week. In 2019, growth continued in the number of new waiting list registrations (12,767) and transplants performed (8,896), including living-donor transplants (524). Compared with 2018, living-donor liver transplants increased 31%. Women continued to have a lower deceased-donor transplant rate and a higher pretransplant mortality rate than men. The median waiting time for candidates with a MELD of 15-34 decreased, while the number of transplants performed for patients with exception points decreased. These changes may have been related to the policy changes that took effect in May 2019, which increased waiting list priority for candidates without exception status. Hepatitis C continued to decline as an indication for liver transplant, as the proportion of liver transplant recipients with alcohol-related liver disease and clinical profiles consistent with non-alcoholic steatohepatitis increased. Graft and patient survival have improved despite changing recipient demographics including older age, higher MELD, and higher prevalence of obesity and diabetes.

Keywords: Liver transplant; allocation; distribution; waiting list.

Similar articles

  • OPTN/SRTR 2017 Annual Data Report: Liver.
    Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Robinson AM, Miller E, Snyder JJ, Israni AK, Kasiske BL. Kim WR, et al. Am J Transplant. 2019 Feb;19 Suppl 2:184-283. doi: 10.1111/ajt.15276. Am J Transplant. 2019. PMID: 30811890
  • OPTN/SRTR 2018 Annual Data Report: Liver.
    Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Foutz J, Miller E, Snyder JJ, Israni AK, Kasiske BL. Kwong A, et al. Am J Transplant. 2020 Jan;20 Suppl s1:193-299. doi: 10.1111/ajt.15674. Am J Transplant. 2020. PMID: 31898413 Review.
  • OPTN/SRTR 2016 Annual Data Report: Liver.
    Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. Kim WR, et al. Am J Transplant. 2018 Jan;18 Suppl 1:172-253. doi: 10.1111/ajt.14559. Am J Transplant. 2018. PMID: 29292603
  • OPTN/SRTR 2015 Annual Data Report: Liver.
    Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. Kim WR, et al. Am J Transplant. 2017 Jan;17 Suppl 1:174-251. doi: 10.1111/ajt.14126. Am J Transplant. 2017. PMID: 28052604
  • OPTN/SRTR 2018 Annual Data Report: Kidney.
    Hart A, Smith JM, Skeans MA, Gustafson SK, Wilk AR, Castro S, Foutz J, Wainright JL, Snyder JJ, Kasiske BL, Israni AK. Hart A, et al. Am J Transplant. 2020 Jan;20 Suppl s1:20-130. doi: 10.1111/ajt.15672. Am J Transplant. 2020. PMID: 31898417 Review.

Cited by

LinkOut - more resources